ライフサイエンスコーパス: tiredness

1 One such internal state could be 'tiredness'.

2 ainly during physical activity and increased tiredness.

3 ent episodes of epigastric pain, nausea, and tiredness.

4 ip swelling, stomach cramping, and objective tiredness.

5 resent targets for overcoming the effects of tiredness.

6 the clinician's experience, motivation, and tiredness.

7 s [53%]), pain (25 cases [47%]), and chronic tiredness (22 cases [42%]), were common.

8 d reinfected CYP 12-months post-testing were tiredness (35.7 and 33.6% respectively) and sleeping dif

9 n symptoms of Sjogren's syndrome are extreme tiredness, along with dry eyes (keratoconjunctivitis sic

10 genetic correlations were identified between tiredness and body mass index (BMI), C-reactive protein,

11 hostatic stress, and subtle symptoms such as tiredness and cognitive impairment should be recognised.

12 Within individual cancer types, tiredness and depression were consistently associated wi

13 anaemia and the patient suffers from chronic tiredness and fatigue, or we do treat it through blood t

14 Self-reported tiredness and low energy, often called fatigue, are asso

15 uction correlated with increases in fatigue (tiredness and sleepiness) and with deterioration in cogn

16 Tiredness and social context moderated this association.

17 ers and the ISI, compared to the question on tiredness and the ISI.

18 to test for shared genetic aetiology between tiredness and up to 29 physical and mental health traits

19 eeting the following criteria: self-reported tiredness and/or trouble falling or staying asleep or sl

20 87% for anxiety, 86% for depression, 65% for tiredness, and 60% for drowsiness.

21 All adults reported nausea, tiredness, and dry heaves in the emetic phase, and 12 (9

22 defined by excessive daytime sleepiness and tiredness, and is associated with increased breathing ef

23 ing moderate-to-severe ESAS scores for pain, tiredness, and lack of appetite and well-being over the

24 mbination of migraines, palpitation, nausea, tiredness, and sleep disorders explained 6.5% of the var

25 for the domains of hypothyroid symptoms and tiredness at 1 year (range, 0-100; higher scores indicat

26 RA fatigue is different from normal tiredness because it is extreme, often not earned, and u

27 ulted in more donation-related symptoms (eg, tiredness, breathlessness, feeling faint, dizziness, and

28 ut higher BMI was associated with anhedonia, tiredness, changes in appetite, and feelings of inadequa

29 n of metabolic dysregulation with anhedonia, tiredness, changes in appetite, and feelings of inadequa

30 IVR-reported changes in pain, weakness, and tiredness; clinical myotonia assessment; quantitative me

31 xine did not improve hypothyroid symptoms or tiredness compared with placebo.

32 Nursing staff believed that tiredness could affect care and communication but had va

33 ith pain, appetite, shortness of breath, and tiredness demonstrating the strongest associations.

34 S) for gastrointestinal complaints, pain and tiredness, drug prescriptions and tissue-Trans-Glutamina

35 e most common presenting symptoms in CD were tiredness/fatigue (80.6%) and abdominal pain (80.4%) whi

36 ng (grade 2 or 3 in 19, grade 4 in one), and tiredness (grade 2 or 3 in 15).

37 stionnaire, including self-perceived health, tiredness, headache and gastrointestinal symptoms.

38 symptoms at month 6 (most frequently extreme tiredness, headache, loss of taste and/or smell, and sho

39 ed increases in urges to smoke (craving) and tiredness in smokers.

40 These results suggest that tiredness is a partly heritable, heterogeneous and compl

41 severe symptom scores (>=4) were highest for tiredness, lack of well-being, and lack of appetite the

42 14, 93.3%), dehydration (n = 13, 86.7%), and tiredness (n = 13, 86.7%).

43 problems, sleep disturbances, drowsiness or tiredness, nausea, sweating, and being restless or overa

44 il did not significantly influence appetite, tiredness, nausea, well-being, caloric intake, nutrition

45 Appetite, tiredness, nausea, well-being, caloric intake, nutrition

46 f sleep-wake quality, daytime attention, and tiredness of health care workers has not yet been establ

47 shold, number of tender points, FIQ fatigue, tiredness on awakening, and stiffness scores, Clinical G

48 nse of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer trea

49 besity, working outside the home, and recent tiredness or fever.

50 oup who received radiotherapy for a PTM) and tiredness or lethargy (36 [39%] in the immediate radioth

51 nk, of whom 19,526 (5.96%) reported fatigue (tiredness or low energy nearly every day over the past t

52 Self-reported tiredness or low energy, often referred to as fatigue, h

53 ), depression (OR, 1.92; 95% CI, 1.59-2.31), tiredness (OR, 1.82; 95% CI, 1.52-2.19), drowsiness (OR,

54 hat do not directly denote somnolence (e.g. 'tiredness' or 'fatigue').

55 nongastrointestinal symptoms of headache and tiredness (P = .010).

56 3.29 (bloating, P = .204), and 0.02 vs 3.20 (tiredness, P = .113).

57 ificant associations were identified between tiredness phenotypic scores and polygenic profile scores

58 t using the terms RA and fatigue, and RA and tiredness, plus scale, questionnaire, inventory, and che

59 mon single-nucleotide polymorphisms for this tiredness question was 8.4% (s.e.=0.6%).

60 th higher scores indicating more symptoms or tiredness, respectively; minimum clinically important di

61 me major depression and premenstrual-related tiredness, sadness, and irritability were assessed twice

62 (baseline Hypothyroid Symptoms score >30 or Tiredness score >40) versus lower symptom burden.

63 onfidence interval [CI], -2.0 to 2.1) or the Tiredness score (3.2+/-17.7 and 3.8+/-18.4, respectively

64 The tiredness score increased from 25.5 at baseline to 28.2

65 that baseline Hypothyroid Symptoms score or Tiredness score modified the effects of L-thyroxine vers

66 change in the Hypothyroid Symptoms score and Tiredness score on a thyroid-related quality-of-life que

67 1-year change in Hypothyroid Symptoms and Tiredness scores (range, 0 to 100; higher scores indicat

68 Symptoms scores greater than 30, and 133 had Tiredness scores greater than 40.

69 Improvements in Tiredness scores were also similar between those receivi

70 .5 points) for infants/toddlers, and daytime tiredness/sleepiness/low energy (6.5 points) and dry cou

71 rs included sleeplessness, feeling 'fed-up', tiredness, stressful life events and a body mass index >

72 Tiredness was evaluated using the Tiredness Symptom Scale.

73 uced anticipated increases in negative mood, tiredness, tension and sickness symptoms and reduced vig

74 Tiredness was evaluated using the Tiredness Symptom Scal

75 That said, tiredness was the strongest predictor across all models.

76 in/cramps, urgency, rectal bleeding, fatigue/tiredness) was reported in the first weeks of treatment,

77 t beta-thalassaemia-Patient-Reported Outcome Tiredness/Weakness domain score (>=3 vs <3).

78 d more severe symptoms, worse ESAS-r scores (tiredness, wellbeing, shortness of breath, and pain), PH